Gyre Therapeutics (GYRE) Other Gross PP&E Adjustments: 2009-2025
Historic Other Gross PP&E Adjustments for Gyre Therapeutics (GYRE) over the last 10 years, with Sep 2025 value amounting to $30.0 million.
- Gyre Therapeutics' Other Gross PP&E Adjustments rose 8.01% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.0 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $27.0 million for FY2024, which is 2.92% up from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Other Gross PP&E Adjustments is $30.0 million, which was up 3.50% from $29.0 million recorded in Q2 2025.
- Over the past 5 years, Gyre Therapeutics' Other Gross PP&E Adjustments peaked at $30.0 million during Q3 2025, and registered a low of -$3.3 million during Q4 2021.
- Over the past 3 years, Gyre Therapeutics' median Other Gross PP&E Adjustments value was $27.3 million (recorded in 2024), while the average stood at $22.3 million.
- As far as peak fluctuations go, Gyre Therapeutics' Other Gross PP&E Adjustments crashed by 87.17% in 2021, and later soared by 162,364.71% in 2024.
- Over the past 5 years, Gyre Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$3.3 million in 2021, then surged by 703.26% to $19.6 million in 2022, then soared by 33.65% to $26.2 million in 2023, then rose by 2.92% to $27.0 million in 2024, then rose by 8.01% to $30.0 million in 2025.
- Its last three reported values are $30.0 million in Q3 2025, $29.0 million for Q2 2025, and $29.1 million during Q1 2025.